Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Homo sapiens | Feb 27, 2024 | ||||||
GSE201655 |
Suboptimization of human transcription factors
|
|
100 | Alexandre P Magalhaes | Feb 27, 2024 | |||
GSE227427 |
Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
|
22 | Shiva Najjary | Feb 27, 2024 | ||||
GSE244107 |
A New Approach Methods Strategy for Risk-based Prioritization of PFAS [hepatocytes]
|
318 | Ivan Rusyn | Feb 27, 2024 | ||||
GSE244109 |
A New Approach Methods Strategy for Risk-based Prioritization of PFAS [cardiomyocytes]
|
197 | Ivan Rusyn | Feb 27, 2024 | ||||
GSE246405 |
Systematic analyses of RNA-binding proteins uncover therapeutically promising vulnerabilities in osteosarcoma
|
14 | Thileepan Sekaran | Feb 27, 2024 | ||||
GSE254592 |
RNA-sequence analysis in periferal blood before and after direct antiviral agent treatment for chronic hepatitis C
|
56 | Kazunori Kawaguchi | Feb 27, 2024 | ||||
GSE254684 |
The NF-κB RelA transcription factor is dispensable for CD8+ T-cell function in acute viral infection and cancer [human]
|
12 | Yenkel Grinberg-Bleyer | Feb 27, 2024 | ||||
GSE254685 |
The NF-κB RelA transcription factor is dispensable for CD8+ T-cell function in acute viral infection and cancer
|
|
20 | Yenkel Grinberg-Bleyer | Feb 27, 2024 | |||
GSE256035 |
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells
|
22 | Ivan Merelli | Feb 27, 2024 | ||||
GSE256136 |
Single-cell sequencing reveals the heterogeneity of pancreatic neuroendocrine tumors under the pattern of genomic instability and histological grading
|
20 | Zeng Ye | Feb 27, 2024 | ||||
GSE256271 |
Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation
|
8 | Stanca Birlea | Feb 27, 2024 | ||||
GSE256435 |
iPSC-derived human sensory neurons reveal a subset of TRPV1 antagonists as anti-pruritic compounds
|
1 | Shi-Yan Ng | Feb 27, 2024 | ||||
GSE256519 |
Deep RNA-Seq of Human Fetal and Adult Heart
|
2 | Hina Chaudhry | Feb 27, 2024 | ||||
GSE256579 |
Histone ChIP-seq from BLaER1 (ENCSR105FGG)
|
2 | ENCODE DCC | Feb 27, 2024 | ||||
GSE256587 |
Histone ChIP-seq from BLaER1 (ENCSR006ANF)
|
2 | ENCODE DCC | Feb 27, 2024 | ||||
GSE256603 |
Histone ChIP-seq from BLaER1 (ENCSR285NFQ)
|
2 | ENCODE DCC | Feb 27, 2024 | ||||
GSE256616 |
Histone ChIP-seq from BLaER1 (ENCSR192IRQ)
|
2 | ENCODE DCC | Feb 27, 2024 | ||||
GSE256644 |
Histone ChIP-seq from BLaER1 (ENCSR010OVI)
|
2 | ENCODE DCC | Feb 27, 2024 | ||||
GSE256663 |
Histone ChIP-seq from BLaER1 (ENCSR285PDU)
|
2 | ENCODE DCC | Feb 27, 2024 | ||||
GSE256668 |
TF ChIP-seq from BLaER1 (ENCSR195PUH)
|
2 | ENCODE DCC | Feb 27, 2024 |